A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy, safety, and tolerability of dexpramipexole administered orally for 24 weeks in participants with eosinophilic asthma (EXHALE-4)

Supported projects > Supported Project by Private Organizations in Other Countries · 2024

Authors: Özlem GÖKSEL

2024-2025, Supported Project by Private Organizations in Other Countries, R & D Project, Continues

View details